Dose Response Curve - Sacral Nerve Stimulation for Faecal Incontinence
Primary Purpose
Fecal Incontinence
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Sensory Threshold
75% of sensory threshold - Amplitude
50% of sensory threshold - Amplitude
Sponsored by
About this trial
This is an interventional treatment trial for Fecal Incontinence focused on measuring Fecal incontinence, Sacral nerve stimulation, Quality of life, DR15.9 Incontinentia alva
Eligibility Criteria
Inclusion Criteria:
- 18 years or older
- Informed consent
- Idiopathic fecal incontinence or Fecal incontinence due to small sphincter defect(≤60 o)
- fecal incontinence after primary/secondary sphincter repair
- Permanent neuromodulator (medtronic InterStim / Interstim II) implanted for at least 12 weeks before entering the study.
- Reduction in fecal incontinence episodes of at least 75% between baseline and latest follow up.(Bowel diary card) or 75% reduction of Wexner Inc. score.
- Willing and competent to fill out diary cards
Exclusion Criteria:
- Colorectal/proctological surgery since IPG-implant
- Pregnancy
- Anorectal Pain
Sites / Locations
- Anal Physiology Laboratory, Surgical Research Section 900, Aarhus University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Experimental
Experimental
Arm Label
Sensory threshold - Amplitude
25% below sensory threshold - Amplitude
50% below sensory threshold - Amplitude
Arm Description
Stimulation amplitude set at sensory threshold.
Stimulation amplitude 75% of sensory threshold.
Stimulation with amplitude set 50% below sensory threshold
Outcomes
Primary Outcome Measures
Number of incontinence episodes Assess number of incontinence episodes.
Assess number of incontinence episodes, by means of bowel habit diary. Four week bowel habit diary will be evaluated three times during the twelve-week protocol perioed.
Secondary Outcome Measures
Assess changes in anorectal volume and pressure with different amplitude.
Resting and maximal anal sphincter pressure will be measured with different amplitude settings. In total three evaluations will be made in the twelve week protocol perioed.
Assess Quality of life after decrease in stimulation amplitude.
Quality of life will be recorded by means of Rockwood faecal incontinence quality of life score. A total of three evaluations will be made every fourth week in the twelve week protocol perioed.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01130870
Brief Title
Dose Response Curve - Sacral Nerve Stimulation for Faecal Incontinence
Official Title
Dose Response Curve - Sacral Nerve Stimulation for Faecal Incontinence
Study Type
Interventional
2. Study Status
Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
April 2010 (undefined)
Primary Completion Date
April 2011 (Actual)
Study Completion Date
June 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine if subsensory stimulation (amplitude) will maintain same continence in patients treated with Sacral Nerve Stimulation (SNS) for faecal incontinence as stimulation with amplitude at sensory threshold.
Detailed Description
Faecal incontinence is a devastating condition with huge impact on quality of life. Sacral Nerve Stimulation (SNS) has since 1995 been a treatment option for patients not obtaining satisfactory continence result with standard non-surgical treatments. SNS is electrical stimulation of the sacral nerve root(s2,3 or 4). Stimulation of this nerve roots results in improved continence. The mechanism of action is at present not well described.
Standard the neuromodulator (pacemaker) stimulate with Frequency 14 Hz, pulse width 210 mic.sec. and amplitude set at sensory threshold. One study by SM. Koch et all confirms that subsensory stimulation can be effective. At present there is no doubled blinded study's to confirm this theory of effective sub sensory stimulation.
The aim of this study is to determine if subsensory stimulation will be as effective as stimulation with amplitude at sensory threshold. This will be investigated in 20 patients who have had at least a reduction in incontinence episodes or Wexner inc. score of 75 % between preimplantation and latest follow up. The patients will be randomized to three different amplitudes. 1: amplitude set at sensory threshold. 2: 75% of sensory threshold. 3: 50% of sensory threshold. The order of the three settings will be random and in a double blinded manner. The interval between these three pacemaker settings is four weeks. Patients serve as there own controls. Stimulation frequency (14 Hz) and pulse width (210 mic-sec) will remain fixed.
Evaluation will be by means of 4 week bowel habit diary and questionnaires (Wexner inc. score / St. Marks Score / Wexner constipation score / Altomares OD-score / IBS-score/ Rockwood FIQoL -score). All patients will be evaluated with anorectal measurements (sphincter strength and anorectal volume measurements) before any changes of stimulation amplitude.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fecal Incontinence
Keywords
Fecal incontinence, Sacral nerve stimulation, Quality of life, DR15.9 Incontinentia alva
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
19 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sensory threshold - Amplitude
Arm Type
Active Comparator
Arm Description
Stimulation amplitude set at sensory threshold.
Arm Title
25% below sensory threshold - Amplitude
Arm Type
Experimental
Arm Description
Stimulation amplitude 75% of sensory threshold.
Arm Title
50% below sensory threshold - Amplitude
Arm Type
Experimental
Arm Description
Stimulation with amplitude set 50% below sensory threshold
Intervention Type
Device
Intervention Name(s)
Sensory Threshold
Intervention Description
Sacral nerve stimulation with amplitude (sensory threshold), Frequency 14 Hz and pulse width 210 mic.sec.
Intervention Type
Device
Intervention Name(s)
75% of sensory threshold - Amplitude
Intervention Description
Sacral nerve stimulation with amplitude (75% of sensory threshold), Frequency 14 Hz and pulse width 210 mic.sec.
Intervention Type
Device
Intervention Name(s)
50% of sensory threshold - Amplitude
Intervention Description
Sacral nerve stimulation with amplitude (50% of sensory threshold), Frequency 14 Hz and pulse width 210 mic.sec.
Primary Outcome Measure Information:
Title
Number of incontinence episodes Assess number of incontinence episodes.
Description
Assess number of incontinence episodes, by means of bowel habit diary. Four week bowel habit diary will be evaluated three times during the twelve-week protocol perioed.
Time Frame
Will be assessed every four weeks during a twelve-week period
Secondary Outcome Measure Information:
Title
Assess changes in anorectal volume and pressure with different amplitude.
Description
Resting and maximal anal sphincter pressure will be measured with different amplitude settings. In total three evaluations will be made in the twelve week protocol perioed.
Time Frame
Will be assessed every four weeks during a twelve-week period
Title
Assess Quality of life after decrease in stimulation amplitude.
Description
Quality of life will be recorded by means of Rockwood faecal incontinence quality of life score. A total of three evaluations will be made every fourth week in the twelve week protocol perioed.
Time Frame
Will be assessed every four weeks during a twelve-week period
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18 years or older
Informed consent
Idiopathic fecal incontinence or Fecal incontinence due to small sphincter defect(≤60 o)
fecal incontinence after primary/secondary sphincter repair
Permanent neuromodulator (medtronic InterStim / Interstim II) implanted for at least 12 weeks before entering the study.
Reduction in fecal incontinence episodes of at least 75% between baseline and latest follow up.(Bowel diary card) or 75% reduction of Wexner Inc. score.
Willing and competent to fill out diary cards
Exclusion Criteria:
Colorectal/proctological surgery since IPG-implant
Pregnancy
Anorectal Pain
Facility Information:
Facility Name
Anal Physiology Laboratory, Surgical Research Section 900, Aarhus University Hospital
City
Aarhus
State/Province
Aarhus C
ZIP/Postal Code
8000
Country
Denmark
12. IPD Sharing Statement
Citations:
PubMed Identifier
23001079
Citation
Duelund-Jakobsen J, Buntzen S, Lundby L, Laurberg S. Sacral nerve stimulation at subsensory threshold does not compromise treatment efficacy: results from a randomized, blinded crossover study. Ann Surg. 2013 Feb;257(2):219-23. doi: 10.1097/SLA.0b013e318269d493.
Results Reference
derived
Learn more about this trial
Dose Response Curve - Sacral Nerve Stimulation for Faecal Incontinence
We'll reach out to this number within 24 hrs